- Third Party Funding in China2020-05-14
- A Booming Market and an Evolving System ...2020-05-07
- Managing China-related COVID-19 Force Ma...2020-04-27
- SAMR Optimizes Antitrust Enforcement to ...2020-04-23
- Trends and Developments in China’s Life...2020-04-03
- Trends and Developments in Pharmaceutica...2020-03-16
- Compliance and Litigation Risks Facing I...2020-03-13
- Analysis on Handling of Contractual Disp...2020-02-25
- China Proposes to Fine Tune Its Anti-Mon...2020-02-09
- China Apps Governance in 2019: Retrospec...2020-01-21
- Interim Measures in Mainland China Possi...2020-01-17
- Shanghai SAMR issued Anti-Monopoly Compl...2020-01-16
- China Stem Cell&Gene Therapy Opportuniti...2020-01-15
- Shanghai Issues Local Antitrust Complian...2020-01-03
- Highlights of China’s Officially Enacte...2019-11-01
- National Security Review in China: Ready...2019-09-26
- China Enacted New Drug Administration La...2019-08-28
- New Rules on Protection of Trade Secrets2019-08-28
- China's Green Light on Stem Cell, Gene D...2019-08-22
- Issues Relating to Occupational Health i...2019-08-07
Articles
Copyright © Zhong Lun Law Firm All rights Reserved ICP No. 05006255-1
For more details, please follow us on WeChat.
